Publication | Closed Access
ErbB-3 Predicts Survival in Ovarian Cancer
222
Citations
30
References
2006
Year
HER3 may represent a new prognostic factor in primary epithelial ovarian cancer. Pending validation, exploration of therapeutic strategies to block HER3 could be warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1